DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma
Sponsored by Barnet Dulaney Perkins Eye Centers
About this study
DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.
DSLT enables newly diagnosed patients to remain well controlled and off medications
Where this study is enrolling
- I'm interested
Barnet Dulaney Perkins Eye Centers
Mesa, Arizona
Who can participate
Inclusion criteria
- ✓Primary open angle glaucoma
- ✓Patients age 30 or greater with an IOP of 18-26 mmHg
- ✓Mild to moderate POAG patients (mild or moderate according to the AAO PPP Guidelines)
- ✓DSLT procedure
Exclusion criteria
- ✕History of prior glaucoma treatment - this includes past medication use (in either eye), previous lasers or incisional surgery
- ✕Angle closure patients
- ✕Ocular Hypertension
- ✕Baseline VF MD of worse than -12dB
- ✕Uncontrolled systemic microvascular disease (eg. HTN, DM)
- ✕Subjects with peri-limbal findings (e.g. melanosis, tumors, extensive pterygium, significant senile arcus and pterygium)
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.